Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 4/20 | 0.55 |
| ▸ | PNMT | P11086 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.48 |
| ▸ | NOS1 | P29475 | 8/20 | 0.47 |
| ▸ | NOS2 | P35228 | 8/20 | 0.47 |
| ▸ | NOS3 | P29474 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NCF1 | P14598 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL646951 | 0.87 | ALDH1A1 (0.43) | LOXL2PNMTENPP2PRMT6NOS1 | |
| SCHEMBL36008 | 0.87 | LOXL2 (0.71) | LOXL2PNMTENPP2PRMT6NOS1 | |
| SCHEMBL10422276 | 0.87 | LOXL2 (0.71) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Water SCHEMBL28545356 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Bromide SCHEMBL29013587 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Ammonia Solution, Strong SCHEMBL6899866 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Hydrochloric Acid SCHEMBL8195914 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| SCHEMBL7883952 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Hydrochloric Acid SCHEMBL6018896 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 | |
| Bromide SCHEMBL28362115 | 0.84 | LOXL2 (0.67) | LOXL2PNMTENPP2PRMT6NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200270287-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | APPLIED BIOSYSTEMS, LLC (US) | 2020-08-27 | — | — | US | disclosed |
| US-9783560-B2 | Reagents useful for synthesizing rhodamine-labeled oligonucleotides | APPLIED BIOSYSTEMS, LLC (US) | 2017-10-10 | — | — | US | disclosed |
| WO-2015049229-A1 | MULTI-COMPONENT EPOXY RESIN COMPOSITION | BASF SE (DE) | 2015-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200270287-A1 | Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides | RTCB, RRM2B, SNRPE | LOXL2 3514/4885PNMT 732/4885ENPP2 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.